Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 237

Results For "ET"

10725 News Found

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
Technology | June 23, 2026

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows


HCG launches breast Cancer Care Clinic in Bengaluru
Healthcare | June 23, 2026

HCG launches breast Cancer Care Clinic in Bengaluru

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted


Parexel biotech incubator to connect early-stage innovation with clinical development expertise
Clinical Trials | June 23, 2026

Parexel biotech incubator to connect early-stage innovation with clinical development expertise

The incubator anchored at the company's global headquarters in Raleighla launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm


Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit
News | June 23, 2026

Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit

As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%


India achieves landmark milestone of 5 lakh organ donation pledges
Policy | June 23, 2026

India achieves landmark milestone of 5 lakh organ donation pledges

As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Pfizer CFO Dave Denton to exit
People | June 23, 2026

Pfizer CFO Dave Denton to exit

Pharma powerhouse names Cecile Guegan interim finance chief


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


MICK Digital empanelled as AMTZ authorized channel partner
Medical Device | June 22, 2026

MICK Digital empanelled as AMTZ authorized channel partner

Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks